IL22 and Alzheimer disease: The demonstration of epigenetic modulations following the application of AD IgG induced infant intrathymic nonatopic T cells to acquire IL-17/IL-22 profile or CD4+CLA+ profile, presenting downregulated miRNA-26a-5p as a certain co-regulator in AD inflammation [129,130].